Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShort-Term Debt repayments
Ratios

Arrowhead Pharmaceuticals (ARWR) Receivables - Other (2019 - 2025)

Arrowhead Pharmaceuticals (ARWR) has disclosed Receivables - Other for 8 consecutive years, with $9.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Receivables - Other changed N/A year-over-year to $9.8 million, compared with a TTM value of $9.8 million through Dec 2025, changed N/A, and an annual FY2021 reading of $100000.0, changed N/A over the prior year.
  • Receivables - Other was $9.8 million for Q4 2025 at Arrowhead Pharmaceuticals, up from $100000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $9.8 million in Q4 2025 and bottomed at $100000.0 in Q3 2021.